ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
637 Views
Tencent's Offer For Bitauto Is A Done Deal
Last Friday, Tencent Holdings (700 HK) and Hammer Capital tabled a preliminary non-binding proposal for Bitauto Holdings Ltd Adr (BITA US) at...
852 Views
Last Week in GER Research: Wuxi Biologics Placement, Budweiser APAC IPO, Slack and CIMC Direct
Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we update on the placement by Wuxi...
458 Views
WuXi Biologics IPO Review - An Opportunity to Get Exposure to Biologics in China
WuXi Biologics (2269 HK) is looking to raise US$461-511m through the issuance of primary (88%) and secondary (12%) shares. Â Proceeds will be used...
1k Views
Just What the Doctor Ordered
This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...
465 Views